A retrospective claims analysis of 2897 matched pairs found hazard ratios of 0.48 to 0.67 for new atopic disease with dupilumab vs systemic corticosteroids in children.
|Videos|May 7, 2021
New Acne Treatments and How to Ensure Compliance
Author(s)Miranda Hester, Morgan Petronelli
In part 2 of our exclusive video interview with Hilary Baldwin, MD, she discusses new treatments for acne and how to ensure compliance of these treatments among your young patients.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Dermatology Times
1
Dupilumab Associated With Lower Atopic March Risk in Pediatric Atopic Dermatitis
2
AAD, HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines
3
GLP-1 Candidacy and Prescribing Considerations in Psoriasis
4
JAK Inhibitors for Alopecia Areata: Selectivity and Pivotal Trial Efficacy
5